In recent years, in large intervention studies (ARED study) the possibility of progression of early AMD to late AMD visusmindernden investigated. This was the one in the 10-year progression rates for different groups of patients with early AMD by different ARED scores with increasing risk probabilities are correlated (soft drusen per eye score 1, hyperpigmentation score 1 per eye, unilateral late AMD 2 scores, as this rresultiert possibility of an individual score of 0-4, 10-year progression-score data ARED 0 = 1.1%, score 1 = 8.5%, score 2 = 26.8%, score 3 = 54.2%, score 4 = 72.1%). When the scores 2-4, these rates of progression through the ARED-medication, on average, in 10-year to 10%.
This medication is for these high-risk patients, therefore, recommended.Another was in nutrition studies that protective effect of omega-3-fatty acids can be observed.Moreover, even the intake of lutein and zeaxanthin in AMD's protective. This is currently in a further intervention studies (ARED-2) were examined.
No comments:
Post a Comment